A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 23, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 10-Q for Q3 FY2027, filed Aug 28, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the MRVL SEC filings page.
Marvell Technology, Inc. (MRVL) reported $8.2B in revenue for fiscal year 2026, up 42.1% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 7 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Marvell's operating leverage converted rapid growth into profit, but cash conversion lagged as receivables and inventory expanded.
FY2026 revenue rose42.1% while gross profit rose75.5% , showing that incremental sales carried more gross profit. Operating margin reached16.1% from-12.5% while absolute R&D still increased; the step-up therefore reflects scale and expense mix, not simply reduced investment.
Net income was
Long-term debt was
Financial Health Signals
Scored against operating companies for FY2026. Each of the six dimensions is a percentile rank within that peer group, and the overall is the average of the dimensions that can be computed. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of Marvell Technology, Inc.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Marvell Technology, Inc. has an operating margin of 16.1%, meaning the company retains $16 of operating profit per $100 of revenue. Among its peers this margin ranks in the lower range, for a profitability score of 24/100. This is up from -12.5% the prior year.
Marvell Technology, Inc.'s revenue surged 42.1% year-over-year to $8.2B, reflecting rapid business expansion. This strong growth earns a score of 83/100.
Marvell Technology, Inc. has a moderate D/E ratio of 0.28. This balance of debt and equity financing earns a leverage score of 59/100.
Marvell Technology, Inc.'s current ratio of 2.01 indicates adequate short-term liquidity, earning a score of 59/100. The company can meet its near-term obligations, though with limited headroom.
Marvell Technology, Inc. converts 17.0% of revenue into free cash flow ($1.4B). This strong cash generation earns a score of 85/100.
Marvell Technology, Inc. generates a 18.7% ROE, indicating limited profit relative to shareholders' investment. This results in a returns score of 26/100. This is up from -6.6% the prior year.
Marvell Technology, Inc. scores 16.27, well above the 2.99 safe threshold. The largest contribution to the score comes from a market capitalization of $205.4B against total liabilities of $8.0B. This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
Marvell Technology, Inc. passes 7 of 9 financial strength tests. 3 of 4 profitability signals pass, 2 of 3 leverage/liquidity signals pass, both operating efficiency signals pass.
For every $1 of reported earnings, Marvell Technology, Inc. generates $0.66 in operating cash flow ($1.8B OCF vs $2.7B net income). This mixed ratio suggests some earnings may rely on non-cash accounting items.
Marvell Technology, Inc. earns $7.06 in operating income for every $1 of interest expense ($1.3B vs $187.3M). This wide margin provides strong safety for debt servicing, even if earnings decline temporarily.
Key Financial Metrics
Earnings & Revenue
Marvell Technology, Inc. generated $2.7B in revenue in Q3 2027. This represents an increase of 36.5% from the same quarter a year earlier. Against the prior quarter it is up 13.3%.
Marvell Technology, Inc. reported $308.0M in net income in Q3 2027. This represents an increase of 58.1% from the same quarter a year earlier. Against the prior quarter it is up 792.8%.
Marvell Technology, Inc. earned $0.33 per diluted share (EPS) in Q3 2027. This represents an increase of 50.0% from the same quarter a year earlier. Against the prior quarter it is up 725.0%.
Not reported for Q3 2027.
Cash & Balance Sheet
Marvell Technology, Inc. generated $478.8M in free cash flow in Q3 2027, representing cash available after capex. This represents an increase of 15.6% from the same quarter a year earlier. Against the prior quarter it is down 0.9%.
Marvell Technology, Inc. held $3.9B in cash against $5.0B in long-term debt as of Q3 2027.
Marvell Technology, Inc. paid $0.06 per share in dividends in Q3 2027. That is unchanged from the same quarter a year earlier. It is unchanged from the prior quarter.
Margins & Returns
Marvell Technology, Inc.'s gross margin was 53.1% in Q3 2027, indicating the percentage of revenue retained after direct costs. This is up 2.8 percentage points from the same quarter a year earlier. Against the prior quarter it is up 1.0 percentage points.
Marvell Technology, Inc.'s operating margin was 16.8% in Q3 2027, reflecting core business profitability. This is up 2.3 percentage points from the same quarter a year earlier. Against the prior quarter it is up 2.7 percentage points.
Marvell Technology, Inc.'s net profit margin was 11.2% in Q3 2027, showing the share of revenue converted to profit. This is up 1.5 percentage points from the same quarter a year earlier. Against the prior quarter it is up 9.8 percentage points.
Marvell Technology, Inc.'s quarterly ROE was 1.7% in Q3 2027: one quarter's net income over shareholder equity, not annualized. This is up 0.2 percentage points from the same quarter a year earlier. Against the prior quarter it is up 1.5 percentage points.
Capital Allocation
Marvell Technology, Inc. invested $741.1M in research and development in Q3 2027. This represents an increase of 42.8% from the same quarter a year earlier. Against the prior quarter it is up 13.6%.
Marvell Technology, Inc. spent $200.0M on share buybacks in Q3 2027, returning capital to shareholders by reducing shares outstanding. That is unchanged from the same quarter a year earlier. It is unchanged from the prior quarter.
Marvell Technology, Inc. invested $126.7M in capex in Q3 2027, funding long-term assets and infrastructure. This represents an increase of 166.7% from the same quarter a year earlier. Against the prior quarter it is down 18.6%.
MRVL Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2710-Q | Q2'2710-Q | Q4'2610-K | Q3'2610-Q | Q2'2610-Q | Q1'2610-K | Q4'2510-K | Q3'2510-Q |
|---|---|---|---|---|---|---|---|---|
| Revenue | $2.7B+36.5% | $2.4B+27.6% | $2.1B+36.8% | $2.0B+57.6% | $1.9B+63.3% | $1.1B-31.8% | $1.5B | $1.3B-10.3% |
| Cost of Revenue | $1.3B+29.0% | $1.2B+22.7% | $1.0B-13.9% | $995.5M+45.3% | $942.9M+48.9% | $590.2M-34.0% | $1.2B | $685.3M-21.0% |
| Gross Profit | $1.5B+44.0% | $1.3B+32.4% | $1.1B+206.2% | $1.0B+72.0% | $952.4M+80.4% | $492.8M-28.9% | $349.4M | $587.6M+6.6% |
| R&D Expenses | $741.1M+42.8% | $652.3M+28.5% | $512.5M+4.9% | $519.0M+6.6% | $507.7M+6.6% | $467.4M+0.7% | $488.6M | $486.7M+1.2% |
| SG&A Expenses | $257.6M+33.6% | $258.4M+38.6% | $189.9M-7.5% | $192.8M-2.3% | $186.4M-6.8% | $209.2M-0.9% | $205.3M | $197.3M-7.4% |
| Operating Income | $459.7M+58.5% | $339.4M+25.4% | $357.8Mn/m | $290.1Mn/m | $270.6Mn/m | -$187.7Mn/m | -$702.8M | -$100.4Mn/m |
| Interest Expense | $58.9M+25.9% | $50.0M+11.6% | $47.9M+5.0% | $46.8M+0.6% | $44.8M-4.3% | $46.1M-15.6% | $45.6M | $46.5M-6.3% |
| Income Tax | $70.3M+80.7% | $48.8M+28.4% | $314.1Mn/m | $38.9M-17.4% | $38.0M+113.5% | -$20.6M-109.2% | -$74.2M | $47.1Mn/m |
| Net Income | $308.0M+58.1% | $34.5M-80.6% | $1.9Bn/m | $194.8Mn/m | $177.9Mn/m | -$193.3Mn/m | -$676.3M | -$193.3Mn/m |
| EPS (Basic) | $0.34+47.8% | $0.04-81.0% | $2.22n/m | $0.23n/m | $0.21n/m | $0.23n/m | -$0.78 | -$0.22n/m |
| EPS (Diluted) | $0.33+50.0% | $0.04-80.0% | $2.20n/m | $0.22n/m | $0.20n/m | $0.23n/m | -$0.78 | -$0.22n/m |
| Diluted Shares (Avg) | 921M+5.8% | 893M+2.0% | 864M-0.2% | 870M+0.5% | 876M+1.2% | N/A | 866M | 866M+0.4% |
Not reported in any period shown, so not listed: EBITDA.
MRVL Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2710-Q | Q2'2710-Q | Q4'2610-K | Q3'2610-Q | Q2'2610-Q | Q1'2610-K | Q4'2510-K | Q3'2510-Q |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $27.6B+33.8% | $26.9B+34.6% | $21.6B+9.5% | $20.6B+1.4% | $20.0B-2.3% | $20.2B-4.8% | $19.7B | $20.3B-6.5% |
| Current Assets | $7.9B+75.5% | $7.5B+94.5% | $5.5B+95.7% | $4.5B+63.3% | $3.8B+44.9% | $3.1B+1.9% | $2.8B | $2.8B-7.0% |
| Cash & Equivalents | $3.9B+221.2% | $3.8B+333.9% | $2.7B+212.7% | $1.2B+51.4% | $885.9M+4.5% | $948.3M-0.3% | $868.1M | $808.7M+11.5% |
| Short-Term Investments | $0n/m | $0n/m | $0 | $0 | $0 | N/A | N/A | N/A |
| Inventory | $1.4B+29.4% | $1.4B+30.8% | $1.0B+18.0% | $1.1B+28.6% | $1.1B+29.6% | $1.0B+19.1% | $859.4M | $817.8M-13.1% |
| Accounts Receivable | $2.2B+52.8% | $1.9B+63.6% | $1.5B+55.0% | $1.5B+36.9% | $1.1B+29.7% | $1.0B-8.3% | $997.9M | $1.1B-12.7% |
| Long-Term Investments | $156.2M+114.0% | $140.1M+188.3% | $128.4M+159.9% | $73.0M+44.8% | $48.6M-3.8% | $48.2M+5.2% | $49.4M | $50.4M+14.3% |
| Goodwill | $13.9B+25.4% | $13.9B+25.5% | $11.1B-4.5% | $11.1B-4.5% | $11.1B-4.5% | $11.6B0.0% | $11.6B | $11.6B0.0% |
| Total Liabilities | $9.0B+25.9% | $8.7B+30.1% | $7.5B+18.6% | $7.2B+17.7% | $6.7B+11.6% | $6.8B+5.9% | $6.3B | $6.1B-6.1% |
| Current Liabilities | $2.5B+4.2% | $2.3B-22.6% | $2.7B+55.2% | $2.4B+55.1% | $2.9B+100.4% | $2.0B+11.7% | $1.8B | $1.5B-17.7% |
| Non-Current Liabilities | $6.5B+36.9% | $6.5B+71.2% | $4.8B+4.5% | $4.8B+4.9% | $3.8B-17.1% | $4.8B+3.7% | $4.6B | $4.5B-1.3% |
| Long-Term Debt | $5.0B+25.1% | $5.0B+66.6% | $4.0B+0.1% | $4.0B-0.7% | $3.0B-26.1% | $3.9B-3.1% | $4.0B | $4.0B-2.3% |
| Total Equity | $18.5B+38.1% | $18.2B+36.8% | $14.1B+5.1% | $13.4B-5.5% | $13.3B-8.1% | $13.4B-9.5% | $13.4B | $14.2B-6.8% |
| Retained Earnings | $1.6Bn/m | $1.3Bn/m | $1.0Bn/m | -$840.0Mn/m | -$983.1Mn/m | -$1.1Bn/m | -$1.3B | -$529.3M-223.7% |
MRVL Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2710-Q | Q2'2710-Q | Q4'2610-K | Q3'2610-Q | Q2'2610-Q | Q1'2610-K | Q4'2510-K | Q3'2510-Q |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $605.5M+31.2% | $638.8M+91.9% | $582.3M+8.6% | $461.6M+50.7% | $332.9M+2.6% | $514.0M-6.0% | $536.3M | $306.4M-39.1% |
| Stock-Based Compensation | N/A | $207.6M+46.1% | N/A | N/A | $142.1M+4.1% | N/A | N/A | N/A |
| Capital Expenditures | $126.7M+166.7% | $155.7M+31.1% | $73.5M-2.0% | $47.5M-1.5% | $118.8M+29.8% | $69.9M-1.5% | $75.0M | $48.2M-11.4% |
| Free Cash Flow | $478.8M+15.6% | $483.1M+125.6% | $508.8M+10.3% | $414.1M+60.4% | $214.1M-8.1% | $444.1M-6.6% | $461.3M | $258.2M-42.4% |
| Investing Cash Flow | -$130.3Mn/m | -$1.4Bn/m | $2.4Bn/m | -$77.2Mn/m | -$94.1Mn/m | -$70.3Mn/m | -$75.5M | -$53.0Mn/m |
| Financing Cash Flow | -$386.0Mn/m | $2.0Bn/m | -$1.5Bn/m | -$45.9Mn/m | -$301.2Mn/m | -$363.5Mn/m | -$401.4M | -$292.4Mn/m |
| Dividends Paid | $53.9M+4.3% | $53.8M+3.9% | $50.8M-2.1% | $51.7M-0.4% | $51.8M0.0% | $51.9M0.0% | $51.9M | $51.9M+0.2% |
| Share Buybacks | $200.0M0.0% | $200.0M-41.2% | $1.3B+550.0% | $200.0M+14.3% | $340.0M+126.7% | $200.0M+100.0% | $200.0M | $175.0M+250.0% |
Not reported in any period shown, so not listed: Depreciation & Amortization.
MRVL Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2710-Q | Q2'2710-Q | Q4'2610-K | Q3'2610-Q | Q2'2610-Q | Q1'2610-K | Q4'2510-K | Q3'2510-Q |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 53.1%+2.8pp | 52.1%+1.9pp | 51.6%+28.5pp | 50.4%+4.2pp | 50.2%+4.8pp | 45.5%+1.8pp | 23.1% | 46.2%+7.3pp |
| Operating Margin | 16.8%+2.3pp | 14.0%-0.2pp | 17.3%+63.6pp | 14.5%+22.4pp | 14.3%+27.4pp | -17.3%-13.3pp | -46.4% | -7.9%+2.4pp |
| Net Margin | 11.2%+1.5pp | 1.4%-8.0pp | 91.6%+136.3pp | 9.7%+24.9pp | 9.4%+28.0pp | -17.8%+4.0pp | -44.6% | -15.2%-3.6pp |
| Return on Equity | 1.7%+0.2pp | 0.2%-1.1pp | 13.5%+18.6pp | 1.5%+2.8pp | 1.3%+2.8pp | -1.4%+0.9pp | -5.1% | -1.4%-0.3pp |
| Return on Assets | 1.1%+0.2pp | 0.1%-0.8pp | 8.8%+12.2pp | 0.9%+1.9pp | 0.9%+1.9pp | -1.0%+0.7pp | -3.4% | -0.9%-0.2pp |
| Current Ratio | 3.17+1.3x | 3.28+2.0x | 2.01+0.4x | 1.88+0.1x | 1.30-0.5x | 1.54-0.1x | 1.60 | 1.79+0.2x |
| Debt-to-Equity | 0.270.0x | 0.270.0x | 0.280.0x | 0.300.0x | 0.22-0.1x | 0.290.0x | 0.30 | 0.280.0x |
| Liabilities-to-Equity | 0.490.0x | 0.480.0x | 0.54+0.1x | 0.53+0.1x | 0.50+0.1x | 0.50+0.1x | 0.47 | 0.430.0x |
| Asset Turnover | 0.100.0x | 0.090.0x | 0.100.0x | 0.100.0x | 0.090.0x | 0.050.0x | 0.08 | 0.060.0x |
| FCF Margin | 17.5%-3.2pp | 20.0%+8.7pp | 24.5%-5.9pp | 20.6%+0.4pp | 11.3%-8.8pp | 41.0%+11.1pp | 30.4% | 20.3%-11.3pp |
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| Marvell Technology, Inc. MRVL | FY2026 | $8.2B | $2.7B | 32.6% | $205.4B | 56/100 |
| NXP Semiconductors N.V. NXPI | FY2025 | $12.3B | $2.0B | 16.5% | $59.2B | 62/100 |
| Monolithic Power Systems, Inc. MPWR | FY2025 | $2.8B | $621.5M | 22.3% | $56.0B | 87/100 |
| Astera Labs ALAB | FY2025 | $852.5M | $219.1M | 25.7% | $44.6B | 69/100 |
| Microchip Technology Inc MCHP | FY2026 | $4.7B | $230.0M | 4.9% | $40.2B | 47/100 |
| Analog Devices, Inc. ADI | FY2025 | $11.0B | $2.3B | 20.6% | $189.5B | 61/100 |
Where Marvell Technology, Inc. Ranks
Frequently Asked Questions
What is Marvell Technology, Inc.'s annual revenue?
Marvell Technology, Inc. (MRVL) reported $8.2B in total revenue for fiscal year 2026. This represents a 42.1% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Marvell Technology, Inc.'s revenue growing?
Marvell Technology, Inc. (MRVL) revenue grew by 42.1% year-over-year, from $5.8B to $8.2B in fiscal year 2026.
Is Marvell Technology, Inc. profitable?
Yes, Marvell Technology, Inc. (MRVL) reported a net income of $2.7B in fiscal year 2026, with a net profit margin of 32.6%.
What is Marvell Technology, Inc.'s EBITDA?
Marvell Technology, Inc. (MRVL) had EBITDA of $2.5B in fiscal year 2026, measuring earnings before interest, taxes, depreciation, and amortization.
How much debt does Marvell Technology, Inc. have?
As of fiscal year 2026, Marvell Technology, Inc. (MRVL) had $2.6B in cash and equivalents against $4.0B in long-term debt.
What is Marvell Technology, Inc.'s gross margin?
Marvell Technology, Inc. (MRVL) had a gross margin of 51.0% in fiscal year 2026, indicating the percentage of revenue retained after direct costs of goods sold.
What is Marvell Technology, Inc.'s operating margin?
Marvell Technology, Inc. (MRVL) had an operating margin of 16.1% in fiscal year 2026, reflecting the profitability of core business operations before interest and taxes.
What is Marvell Technology, Inc.'s net profit margin?
Marvell Technology, Inc. (MRVL) had a net profit margin of 32.6% in fiscal year 2026, representing the share of revenue converted into profit after all expenses.
Does Marvell Technology, Inc. pay dividends?
Yes, Marvell Technology, Inc. (MRVL) paid $0.24 per share in dividends during fiscal year 2026.
What is Marvell Technology, Inc.'s return on equity (ROE)?
Marvell Technology, Inc. (MRVL) has a return on equity of 18.7% for fiscal year 2026, measuring how efficiently the company generates profit from shareholder equity.
What is Marvell Technology, Inc.'s free cash flow?
Marvell Technology, Inc. (MRVL) generated $1.4B in free cash flow during fiscal year 2026. That is unchanged from the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Marvell Technology, Inc.'s operating cash flow?
Marvell Technology, Inc. (MRVL) generated $1.8B in operating cash flow during fiscal year 2026, representing cash generated from core business activities.
What are Marvell Technology, Inc.'s total assets?
Marvell Technology, Inc. (MRVL) had $22.3B in total assets as of fiscal year 2026, including both current and long-term assets.
What are Marvell Technology, Inc.'s capital expenditures?
Marvell Technology, Inc. (MRVL) invested $354.1M in capital expenditures during fiscal year 2026, funding long-term assets and infrastructure.
How much does Marvell Technology, Inc. spend on research and development?
Marvell Technology, Inc. (MRVL) invested $2.1B in research and development during fiscal year 2026.
What is Marvell Technology, Inc.'s current ratio?
Marvell Technology, Inc. (MRVL) had a current ratio of 2.01 as of fiscal year 2026, which is generally considered healthy.
What is Marvell Technology, Inc.'s debt-to-equity ratio?
Marvell Technology, Inc. (MRVL) had a debt-to-equity ratio of 0.28 as of fiscal year 2026. We compute it as long-term debt divided by total shareholder equity, where long-term debt is the noncurrent part of the company's borrowings, so debt due within the next twelve months is not counted.
What is Marvell Technology, Inc.'s liabilities-to-equity ratio?
Marvell Technology, Inc. (MRVL) had a liabilities-to-equity ratio of 0.56 as of fiscal year 2026, which is total liabilities divided by total shareholder equity. Total liabilities counts every obligation on the balance sheet (payables, deposits, insurance reserves and deferred taxes as well as borrowings), so this ratio usually runs well above debt-to-equity.
What is Marvell Technology, Inc.'s return on assets (ROA)?
Marvell Technology, Inc. (MRVL) had a return on assets of 12.0% for fiscal year 2026, measuring how efficiently the company uses its assets to generate profit.
What is Marvell Technology, Inc.'s P/E ratio?
Marvell Technology, Inc. (MRVL) trades at 76.9x earnings, its market capitalization divided by $2.7B net income, FY2026. The market capitalization is $205.4B as of Oct 23, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is Marvell Technology, Inc.'s price-to-sales ratio?
Marvell Technology, Inc. (MRVL) trades at 25.1x sales, its market capitalization divided by $8.2B revenue, FY2026. The market capitalization is $205.4B as of Oct 23, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is Marvell Technology, Inc.'s Altman Z-Score?
Marvell Technology, Inc. (MRVL) has an Altman Z-Score of 16.27, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is Marvell Technology, Inc.'s Piotroski F-Score?
Marvell Technology, Inc. (MRVL) has a Piotroski F-Score of 7 out of 9, indicating strong financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Marvell Technology, Inc.'s earnings high quality?
Marvell Technology, Inc. (MRVL) has an earnings quality ratio of 0.66x, considered mixed quality. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can Marvell Technology, Inc. cover its interest payments?
Marvell Technology, Inc. (MRVL) has an interest coverage ratio of 7.06x, meaning it can comfortably cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
How financially healthy is Marvell Technology, Inc.?
Marvell Technology, Inc. (MRVL) scores 56 out of 100 on our Financial Health Score, indicating moderate standing within its operating companies peer group. The score is the average of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.